Fuad El-Hibri Organization

 Originally posted on  Submitted by admin on Mon, 04/02/2012 - 07:43.

• admin's blog
• Read more

 ROCKVILLE, Md.–(BUSINESS WIRE)–Mar. 22, 2012– Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has received a multi-year grant from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to advance the development of MVA85A, a candidate vaccine against tuberculosis (TB).

ROCKVILLE, Md.–(BUSINESS WIRE)–Feb. 20, 2012– Emergent BioSolutions Inc. (NYSE: EBS) announced today that the company will be webcasting its corporate overview presentation at the 32nd Annual Cowen and Company Health Care Conference in Boston on Monday, March 5, 2012 at 3:40 PM Eastern.

A webcast of this presentation will be available both live and by replay, accessible from the Emergent website http://www.emergentbiosolutions.com under “Investors”.

 ROCKVILLE, Md.--(BUSINESS WIRE)--Jan. 30, 2012-- Emergent BioSolutions Inc. (NYSE: EBS) announced today that it will report financial results for the fourth quarter and full year 2011 on Thursday, March 8, 2012, after market close.

TAKREEM was created as a venue in which to recognize outstanding accomplishments of Arab men and women. Through the TAKREEM Achievement Awards excellence in the Arab world is identified and highlighted, communicating to the level of experience and expertise among organizations and individuals present among Arabs living throughout the world.

 Fuad El-Hibri, chairman and chief executive officer of Emergent BioSolutions Inc.,(NYSE: EBS) announced that, in response to solicitation RFP-2011-N-13414, it has received an award to supply the U.S.

 The El-Hibri Charitable Foundation has announced that internationally acclaimed author and educator   Submitted by admin on Sat, 10/01/2011 - 04:40.

• admin's blog
• Read more

Emergent BioSolutions Inc.